{"schema_version":"secwatch.filing_event.v1","accession":"0001398733-26-000056","form_type":"8-K","ticker":"AQST","cik":"0001398733","company_name":"Aquestive Therapeutics, Inc.","filed_at":"2026-10-14T11:21:15+00:00","discovered_at":"2026-10-14T11:25:00.233759+00:00","generated_at":"2026-10-14T11:25:05.568718+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aquestive licenses LIBERVANT seizure-cluster film to Eton for $10M upfront, up to $47.5M milestones","bullets":["Aquestive received a $10.0M upfront license fee from Eton for exclusive U.S. rights to LIBERVANT (diazepam) buccal film for epilepsy seizure clusters.","Up to $47.5M milestones: $10M at first U.S. commercial sale (cut to $5M absent full FDA approval for ages 2-5), $2.5M for ages 6-11, $35M on net sales.","Aquestive also gets mid-teens royalties on U.S. net sales and serves as exclusive manufacturer under a 20-year supply agreement.","LIBERVANT holds FDA tentative approval; full approval for ages 12+ expected after VALTOCO orphan exclusivity lapses Jan 10, 2027; launch targeted April 2027.","Type 9 NDA to add ages 6-11 has a PDUFA date of March 29, 2027; U.S. seizure rescue market exceeds $450M annually."],"urls":{"canonical":"https://secwatch.observer/filing/0001398733-26-000056","json":"https://secwatch.observer/filing/0001398733-26-000056.json","markdown":"https://secwatch.observer/filing/0001398733-26-000056.md","text":"https://secwatch.observer/filing/0001398733-26-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1398733/000139873326000056/0001398733-26-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1398733/000139873326000056/aqst-20261013.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-14T11:25:05.568718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}